Plant-derived Pharmaceuticals
Principles and Applications for Developing Countries
Published on 29. October 2014
Book
Hardback
180 pages
978-1-78064-343-4 (ISBN)
Description
Describing recent developments in the engineering and generation of plants as production platforms for biopharmaceuticals, this book includes both vaccines and monoclonal antibodies. It has a particular emphasis on targeting diseases which predominate in less developed countries, encompassing the current state of technologies and describing expression systems and applications. This book also includes a variety of vaccine case studies, protecting against pervasive infectious diseases such as rabies, influenza and HIV.
More details
Series
Language
English
Place of publication
Wallingford
United Kingdom
Target group
College/higher education
Product notice
sewn/stitched
Cloth over boards
Dimensions
Height: 244 mm
Width: 173 mm
Thickness: 15 mm
Weight
576 gr
ISBN-13
978-1-78064-343-4 (9781780643434)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
E-Book
10/2014
CABI Publishing
€58.49
Available for download
Persons
Kathleen L Hefferon, Visiting scientist, University of Toronto, Canada
Editor
University of Toronto, Canada
Contributions
Agriculture and Agri-Food Canada, Canada
University of California, Davis, USA
Arizona State University, USA
University of Cape Town, Rondebosch, South Africa
Kentucky BioProcessing, USA
Centre for Infection, St George's University of London, UK
AIT Austrian Institute of Technology, Austria
Medicago Inc., Canada
Protalix Biotherapeutics, Israel
Content
1: Introduction, and the Promise of a Plant-derived Vaccine for Hepatitis B Virus 2: Protein Body-inducing Fusions for Recombinant Protein Production in Plants 3: Expression of Recombinant Proteins in Plant Cell Culture 4: Plant-derived Monoclonal Antibodies as Human Biologics for Infectious Disease and Cancer 5: Plant-produced Virus-like Particles 6: Expression of the Capsid Protein of Human Papillomavirus in Plants as an Alternative for the Production of Vaccines 7: Patenting of Plant-made Recombinant Pharmaceuticals and Access in the Developing World 8: Case Study 1: Rabies 9: Case Study 2: Plant-made HIV Vaccines and Neutralizing Antibodies 10: Case Study 3: The Search for a Plant-made Vaccine for Pandemic Influenza Virus